journal article Dec 12, 2014

Melatonin and its metabolites as copper chelating agents and their role in inhibiting oxidative stress: a physicochemical analysis

Journal of Pineal Research Vol. 58 No. 1 pp. 107-116 · Wiley
View at Publisher Save 10.1111/jpi.12196
Abstract
AbstractThe copper sequestering ability of melatonin and its metabolites cyclic 3‐hydroxymelatonin (3OHM), N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine (AFMK), and N1‐acetyl‐5‐methoxykynuramine (AMK) was investigated within the frame of the Density Functional Theory. It was demonstrated that these compounds are capable of chelating copper ions, yielding stable complexes. The most likely chelation sites were identified. Two different mechanisms were modeled, the direct‐chelation mechanism (DCM) and the coupled‐deprotonation‐chelation mechanism (CDCM). It is proposed that, under physiological conditions, CDCM would be the main chelation route for Cu(II). It was found that melatonin and its metabolites fully inhibited the oxidative stress induced by Cu(II)‐ascorbate mixtures, via Cu(II) chelation. In the same way, melatonin, AFMK, and 3OHM also prevented the first step of the Haber–Weiss reaction, consequently turning off the ˙OH production via the Fenton reaction. Therefore, it is proposed that, in addition to the previously reported free radical scavenging cascade, melatonin is also involved in a concurrent ‘chelating cascade’, thereby contributing to a reduction in oxidative stress. 3OHM was identified as the most efficient of the studied compounds for that purpose, supporting the important role of this metabolite in the beneficial effects of melatonin against oxidative stress.
Topics

No keywords indexed for this article. Browse by subject →

References
77
[2]
Sandstead HH "Requirements and toxicity of essential trace elements illustrated by zinc and copper" Am J Clin Nut (1995) 10.1093/ajcn/61.3.621s
[3]
Safety guidelines for copper in water

DJ Fitzgerald

The American Journal of Clinical Nutrition 1998 10.1093/ajcn/67.5.1098s
[4]
Copper toxicity, oxidative stress, and antioxidant nutrients

L Gaetke

Toxicology 10.1016/s0300-483x(03)00159-8
[9]
Gaggelli E "Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis)" Chem Rev (2012)
[20]
Metals, Toxicity and Oxidative Stress

M. Valko, H. Morris, M. Cronin

Current Medicinal Chemistry 10.2174/0929867053764635
[22]
Undetectable Intracellular Free Copper: The Requirement of a Copper Chaperone for Superoxide Dismutase

T. D. Rae, P. J. Schmidt, R. A. Pufahl et al.

Science 10.1126/science.284.5415.805
[23]
Harris E "The transport of copper" Prog Clin Biol Res (1993)
[26]
The Pecking Order of Free Radicals and Antioxidants: Lipid Peroxidation, α-Tocopherol, and Ascorbate

G.R. Buettner

Archives of Biochemistry and Biophysics 10.1006/abbi.1993.1074
[27]
Crichton RR "Iron chelators and their therapeutic potential" Met Ions Biol Syst (2004)
[34]
Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury

Mohamed Amine Zaoualí, Russel J. Reiter, Susagna Padrissa‐Altés et al.

Journal of Pineal Research 10.1111/j.1600-079x.2010.00831.x
[38]
Tan DX "Melatonin: a potent, endogenous hydroxyl radical scavenger" Endocr J (1993)

Showing 50 of 77 references

Metrics
173
Citations
77
References
Details
Published
Dec 12, 2014
Vol/Issue
58(1)
Pages
107-116
License
View
Funding
SEP-CONACYT Award: 167491
Cite This Article
Annia Galano, Manuel E. Medina, Dun Xian Tan, et al. (2014). Melatonin and its metabolites as copper chelating agents and their role in inhibiting oxidative stress: a physicochemical analysis. Journal of Pineal Research, 58(1), 107-116. https://doi.org/10.1111/jpi.12196